Communicating about screening
Access status:
Open Access
Type
ArticleAbstract
Informed choice is important for screening, but not everyone wants or is able to analyse research data. Vikki Entwistle and colleagues propose a new approach to communication People are offered a wide range of screening tests by diverse providers. For example: maternal and child ...
See moreInformed choice is important for screening, but not everyone wants or is able to analyse research data. Vikki Entwistle and colleagues propose a new approach to communication People are offered a wide range of screening tests by diverse providers. For example: maternal and child health services screen for genetic conditions and developmental problems; general practitioners screen for cardiovascular risk factors; NHS programmes screen for bowel, breast, and cervical cancer; and commercial providers offer various health assessments, including body and gene scans. Provision of tests is not well regulated, and there is a bewildering amount of information of variable accuracy in the public domain.1 It is unclear how healthcare providers should communicate about screening in order to support appropriate uptake. And what constitutes appropriate uptake is also contested because of disagreements about the merits of particular tests and tensions between concerns to promote health and to respect autonomy.2 3 4 Debates about communication have tended to consider two types of approach, which we call “be screened’ and “analyse and choose.” We consider their problems and propose a third approach, “consider an offer.”
See less
See moreInformed choice is important for screening, but not everyone wants or is able to analyse research data. Vikki Entwistle and colleagues propose a new approach to communication People are offered a wide range of screening tests by diverse providers. For example: maternal and child health services screen for genetic conditions and developmental problems; general practitioners screen for cardiovascular risk factors; NHS programmes screen for bowel, breast, and cervical cancer; and commercial providers offer various health assessments, including body and gene scans. Provision of tests is not well regulated, and there is a bewildering amount of information of variable accuracy in the public domain.1 It is unclear how healthcare providers should communicate about screening in order to support appropriate uptake. And what constitutes appropriate uptake is also contested because of disagreements about the merits of particular tests and tensions between concerns to promote health and to respect autonomy.2 3 4 Debates about communication have tended to consider two types of approach, which we call “be screened’ and “analyse and choose.” We consider their problems and propose a third approach, “consider an offer.”
See less
Date
2008-01-01Publisher
BMJLicence
Creative Commons Attribution Licence CC BY 4.0, https://creativecommons.org/licenses/by/4.0/Citation
Entwistle V, Carter SM, Trevena L, Flitcroft K, Irwig L, McCaffrey K, Salkeld G. Communicating about screening. BMJ 2008; 337:789-791.Share